drugset / Trial / NCT01415401
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to assess the efficacy and tolerability of changing to AZARGA® from prior brimonidine 0.2%/timolol 0.5% fixed combination (COMBIGAN®) therapy in patients with open-angle glaucoma or ocular hypertension and uncontrolled intraocular pressure (IOP).
Timeline
- Start
- 2011-09
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brinzolamide 1% / timolol 0.5% maleate fixed combination | Unknown | 0.5 % | Topical |
| Subject | Brinzolamide 1% / timolol 0.5% maleate fixed combination | Unknown | 1 % | Topical |